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Abstract The guest editor (AM) provides his perspective
on the most recent advances on nucleoside diphosphate
kinase (NDPK, otherwise known as AWD or NM23)
showcasing phospho-histidine biochemistry and its impact
on diverse pathology when disordered. His co-author (SO)
provides state-of-the-art analyses from the European
institute of Bioinformatics in an appendix to support the
most recent advances made by the NDPK community.
Unfortunately, to those outside the ﬁeld, NDPK is often
dismissed as a tiny ‘ancient housekeeper’ protein found in
marine sponges, social amoebae, worms, fruit ﬂies, rodents
and humans but the state-of-the-art papers overviewed here
show that NDPK does not act simply in mindless rote,
inter-converting cellular ‘energy currencies’. That two
NDPK isoforms regulate fetal erythroid lineage is a
developmental case in point. Seminal Cancer Research UK
support is gratefully acknowledged that generated addi-
tional resources to enable the NDPK community to meet in
Dundee in 2007 (www.dundee.ac.uk/mchs/ndpk; next
meeting is planned: 2010/Mannheim-Heidelberg). The
presented papers illustrate the point that when scientists are
left alone ‘shut up in the narrow cell of their laboratory’ (as
the philosopher Ortega once said, a sentiment echoed by
Erwin Schro ¨dinger), then progress will ultimately occur
bridging the gap between specialization and translation for
human beneﬁt. To aid translation, this overview initially
introduces the NDPK family to the non-specialist, who
serendipitously ﬁnds these proteins in their biology. This is
immediately followed by examples of the diverse biology
generated by this self-aggregating group of multi-func-
tional proteins and ﬁnally capped by an emerging idea
explaining how this diversity might arise.
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Introduction
This overview is in four parts. The ﬁrst is for the public
interested in how the simplest unit of human life, the cell,
transfers its self-generated energy to internal proteins to
perform useful work, particularly in relation to the spread
of cancer that is very much in the news these days. The
second is for the serendipitous scientist, who unexpectedly
stumbles upon a nucleoside diphosphate kinase (NDPK
otherwise known as AWD or NM23) family member as an
interacting protein in their biology. Because re-discovery is
a leitmotif for NDPK, the means to access an interactive
resource housed at the European Bioinformatic Institute
(EBI) is appended by the co-author Sandra Orchard to aid
understanding for new entrants to the ﬁeld of the emerging
‘interactome’ of this family of proteins, some of which are
protein histidine kinases (also called histidine phospho-
transferases). The third part is for cell and developmental
biologists interested in how cellular energy located on
phosphorylated histidine (phospho-histidine or p-His) is
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endocytosis, thereby altering surface expression of plasma
membrane protein receptors. This emerging idea provides
one integrated example of a key NDPK function that might
explain why so many scientists keep re-discovering this
enigmatic phosphorylation of histidine in their biology.
The fourth, of necessity interspersed amongst the earlier
parts, arises from AM’s privileged position in reviewing
and sending out for anonymous peer-review each of the
manuscripts in this series, with due apology to those whose
manuscripts were rejected. Throughout, his personal view
on areas of uncertainty and potential for advance are
highlighted. Space limitations preclude review of the ori-
ginal biochemistry showcased in earlier meetings of the
NDPK community that were summarized in special issues
(2000/2003) of the Journal of Bioenergetics and Bio-
membranes. Thus, readers should consult NDPK luminar-
ies therein and textbook authors for their original work as
embedded pillars that laid the foundations for the present
series over the last 50 years. Their illustrious names, too
numerous to list, are peppered throughout the papers and
also referenced herein by the contributors to the Dundee
meeting. As Isaac Newton once said, he only advanced his
understanding of gravity by standing on the shoulders of
giants; this review has the same leitmotif for AM towards
NDPK, but *320 years on.
Methods
It is now a condition of my laboratory support from the
Wellcome Trust (grants: WT086370/WT075237 to AM)
that public understanding of science is maximized. Here,
an attempt is made to bridge the gap between complex
histidine biochemistry that generates phosphotransferase
activity (sometimes called histidine kinase activity) and
public understanding by writing a ‘methods’ section that is
suitable for a scientiﬁcally literate audience.
NDPK and the origami of DNA
DNA is shorthand for deoxyribose nucleic acid and the
general public is familiar with the concept of nuclear base
pairs (deﬁned below) specifying the fantastic ﬁdelity of the
DNA double helix during cell division (A only goes with T,
G only with C). Yet, scientists still cannot agree exactly
how the matching of base pairing (AT, GC) actually occurs
in the cell [1]. The latest models suggest that discriminating
the correct (say AT) from the incorrect (say GT) base
pairing is at least a three stage process containing ‘check
points’ or ‘energy hills’ involving many cellular proteins.
Some of these proteins are also enzymes—cellular proteins
acting as catalysts. These proteins are in contact with one
another and with DNA [1]. This overview is about one such
protein/enzyme/catalyst. To understand its function, let us
use the archetypal hydrophobic base in DNA: adenine (A
for short) as an example to understand the nature of the
catalysis performed by this particular enzyme. To make
DNA, the cell makes a ‘sweeter’ adenine derivative called a
nucleoside. Nucleosides are the building blocks of DNA
formed when a water soluble sugar is covalently attached to
the oily adenine base, for example. Similar sugary modiﬁ-
cations apply to the functional units of all DNA bases (G, C
and T). In DNA,the sugar in question has 5carbons in a ring
belonging to the ribose family (actually, deoxyribose, the D
in DNA; ribose, which has one extra oxygen atom is found
in the more unstable nucleic acid, RNA). For example,
adenine plus ribose becomes the nucleoside, adenosine
(guanine becomes guanosine etc.).
However, to become energetically useful to a cell, fur-
ther nucleoside lengthening occurs when two or more
negative charges in the form of one or more (doubly neg-
atively charged) phosphates (PO4
=) are attached to each of
the above nucleosides. This added chain of polyphosphates
creates mono-(M), di-(D) or tri-(T) phosphates of nucleo-
sides (shorthand: AMP, ADP, ATP, respectively). This
combination of base-sugar-phosphates is called a nucleo-
tide (AMP, ADP, ATP, in the case of adenosine as
nucleoside; GMP, GDP, GTP when guanosine is present
etc.). When nucleotides are joined together in a spiral
chain, the classical DNA spiral (helix) is formed. This is a
smooth structure but whenever clusters of GC repeats occur
(so called GC rich regions of DNA), the helix kinks, cre-
ating sign posts for other proteins to attach [2]. At these
kinks, some of the DNA manipulation takes place by an
enzyme called nucleoside diphosphate kinase (NDPK) that
not only binds to GC-rich DNA but also can strongly bind
other parts of DNA after helix cleavage [2]. In other parts
of the cell, remote from DNA, NDPK also controls the
transmission of cell energy to do useful work between
different cell compartments [3]. Thus at one level, this
overview is also about the relationship between cell energy
(located in building blocks of DNA called nucleotides) and
the NDPK enzyme family that can, not only digest DNA
(one base at a time) but, can also act as a sign post towards
nearby genes in the vast tracts of ‘non-coding’ DNA [2].
These NDPK-interacting regions of DNA are also known
as G4 regions because of their clover-leaf shape and are
important promoters of gene activation across phyla [2].
GC-rich, G4 motifs are also found at the periphery of
chromosomes being located at the end structure (telomere)
and play a role in the maintenance of chromosome length
[2]. Chromosome length is important for the longevity of
an organism. Some members of this NDPK enzyme family
can control G4 regions, which are in turn controllers of
adjacent genes encoded by the DNA, thereby stimulating
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acting as ‘masters of the developmental universe’ in the
embryo (the essential early gene C-MYC is an example
without which fetal cells cannot develop). Amazingly [3],
selected members of this versatile NDPK family can also
simultaneously control the layering pattern of fatty acid
membranes lying outside the nucleus (i.e. in the absence of
DNA). They apparently do so by bridging the nearby
regions of cell’s onion skin like fatty internal layers in two
different cellular compartments: the cell’s power stations
(mitochondria) and the adjacent folded cellular internal
layers: the endoplasmic reticulum (ER).
Understanding NDPK, overcoming the nomenclature
barrier
To understand NDPK, its best understood function is
described. Sometimes, nucleotides are referred to as nucle-
oside phosphates (mono, di, etc.). These should be consid-
ered as synonyms. When the interchange between di- and
tri-phosphates of nucleosides is catalyzed in a cell, this
alternative nomenclature gives rise to the original name for
the protein that acts to lengthen the phosphate on one
nucleotide subclass—the nucleoside (N) diphosphates (DP).
Thus, NDP-kinase (NDPK) is an enzyme that adds a phos-
phate to target proteins—the textbook deﬁnition of a protein
kinase [4]. Yet, even this role is subtly different from
‘normal’ protein kinases. As an example of ‘normality’, in
cell membranes, there exists an NDPK-interacting protein
kinase called AMP-activated kinase (AMPK) that senses
cell energy [4]. Normally, during the mode of action of
classical protein kinases such as AMPK and related kinases
suchasthecAMPactivatedkinase(PKA,thatusesacircular
variant of AMP, cAMP, as a regulator rather than AMP
itself), a kinase-trapped phosphate (transiently fractured
from ATP) is transferred to a nearby kinase-trapped target
protein. Thus kinases such as AMPK and PKA when stim-
ulated by their cognate activators (AMP, cAMP, respec-
tively) add phosphate to sites on their respective target
proteins and such protein kinases ﬁnd their targets using
different recognition motifs near their respective phospho-
transfersites.However,twoimportantcaveatsareillustrated
here for NDPK and its targets—ﬁrst, NDPK can detach and
transfer the terminal phosphate from GTP, UTP etc., as well
as from ATP. Very few protein kinases use more than one
substrate. Second, the ultimate recipient target for this
accrued phosphate is not necessarily a nucleotide and may
be a protein [5]. As we shall see, the recipient site of the
phosphate donated by NDPK can be onto a histidine on the
target protein which differs from the corresponding PKA or
AMPK recipient sites. In summary, NDPK has a phospho-
transferase function: ﬁrst to a nucleotide or second to a
histidine (His) in a chain of amino acids.
Nucleosides with different numbers of phosphates
transfer cell energy
Cells need energy to perform useful work and are no dif-
ferent from any thermodynamic engine that utilizes a cycle
ﬁrst characterized by Carnot in France; now eponymously
named. For example, your refrigerator uses a Carnot cycle
of condensed gases to transfer heat energy to the kitchen.
Cells are no different and transfer phosphate at high energy
(fractured from nucleoside tri-phosphates) to nucleosides
with lower energy (nucleoside di-phosphates; this conver-
sion is the catalyst role of NDPK in a cell). For example,
ATP, or adenosine tri-phosphate, is the high cellular energy
‘particle’ but there are many other (interconvertable) forms
of energy in a cell (ADP, GDP, GTP, UDP UTP, AMP, but
only the NDP species are available to NDPK).
However, when a nucleotide such as ATP is added to
water, nothing much happens. There is no ﬁzz, a damp
squib. This disappointing lack of reaction occurs because
the 30–50 kJ per mole of energy locked up in the phos-
phates (thermodynamically ‘Carnot’ available) is held back
by the kinetic stability of the locked phosphate (an energy
barrier exists to breakdown). A moment’s thought reveals
that if ATP did happen to ﬁzz in water, then its energy
would be lost as heat and ATP could never perform a
Carnot cycle to do cellular work and DNA would not exist.
To release this pent up nucleotide energy, cells need cat-
alysts (kinases as in this series of papers) which are
themselves made of chains of amino acids constituting
proteins that are folded up like nano-sized balls of spaghetti
and nano-sheets of pasta. Together with a critical role of
divalent ions in catalysis, it is the arrangement and sub-
types of these nano-chains of spirals and nano-sheets of
amino acids that can create exquisitely sculpted cavities
that trap small molecules. Thus protein kinases such as
NDPK are themselves neatly folded to create highly spe-
ciﬁc molecular tweezers that grip tri-nucleotides so pre-
cisely that NDPK can pick-pocket just the terminal
phosphate on the tri-nucleotide after imprisonment. Like
Robin Hood, they take from the energetically rich and give
phosphate to the energy-poor recipient. Unlike Robin Hood
singular, there is more than one such (Robin-Hoods-
NDPK) hiding in different parts of the cellular forest.
Making nucleotides ﬁzz
Unusually, inside NDPK, this string-sheet nano-mix cre-
ates a dynamic pocket, where the tri-phosphate reverses in,
phosphate ﬁrst, to be trapped. Lurking at the bottom of the
pocket is a dual action molecular phosphate cleavage
device and phosphate trap, an N–P link [5]. This ‘backing
in’ of phosphate distinguishes NDPK from all conventional
protein kinases (sometimes called the kinome). In the latter
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ATP) enters head ﬁrst using the base and sugar as recog-
nition signals. However, for NDPK, having split the P–P
bond between the terminal and penultimate phosphate in
ATP, the nucleotide pocket retains the newly cleaved
phosphate in a special way maintaining its P–P high energy
by a new but transient covalent linkage to a nitrogen (N)
molecule located on a histidine (His) ring (usually His18 or
H118 in mammals; but see caveats below). This N–P
linkage, its location on the histidine ring, and its detection
in cells are described in detail by Paul Attwood’s group in
Australia [5]. As we shall see when drug interactions are
considered with NDPK, p-His bearing NDPK is different
from NDPK and can then transfer this high-energy, trap-
ped, N–P his-phosphate. NDPK, having kept hold of the
terminal phosphate from the ﬁrst bound tri-nucleotide, can
also pass it on to a later (incoming) di-nucleotide. This
function exists in addition to its ‘kinase’ (phospho-trans-
ferase) function towards proteins. David Kaetzel [6]
describes progress in discriminating between these possible
fates for p-His phosphate from H118. The ﬁrst role only
creates a phospho-transferase function, while the second
creates a protein kinase function that has wide biology and
his group shows that in some cases, NDPK isoforms can
even covalently attach to phosphates in cleaved DNA itself
[6]. His focus makes an interesting comparison with others
looking at DNA-NDPK interactions at GC-rich regions [2].
Irrespective of the ﬁnal phospho-destination, the net result
is that NDPK transfers that farthest phosphate recently
cleaved from any incoming combination of [base-(deox-
y)ribose-(phosphate-phosphate-phosphate)] to one or more
targets, whether they be another amino acid or not. When
the recipient is a protein, this process is called protein
phosphorylation and imparts negative charges to the target
protein, which in turn changes target shape and function
(i.e. work is done). When the target is another nucleoside
di-phosphate, then ‘iso-potential’ cellular energy conver-
sion has occurred to generate new particles of equivalent
energy but no net work is done at this stage (hence phos-
pho-transferase), but different work can be done at the later
stage (say modiﬁcation of G protein action, as described
below). These two processes are the manner by which
NDPK uses and transfers energy, ultimately to do molec-
ular work.
The difﬁcult problem of ﬁnding phosphohistidine
on proteins
When a kinase target receiving phosphate from a conven-
tional protein kinase such as PKA is studied in vitro, it is
common practice to wait several minutes for phosphate
transfer to occur at 30–37C after adding the kinase to its
substrate. Thus, in vitro at least, phosphorylation is a
relatively slow process. PKA catalyses phosphate transfer
from ATP to the OH groups on serine (or threonine) resi-
dues located on its substrates. Furthermore, adding GTP to
PKA and substrate yields very little phosphate transfer
showing that PKA can discriminate between bases, pre-
ferring ATP. Yet, when the guest editor accidentally
entered the NDPK ﬁeld, see papers quoted in reference [4],
within seconds of adding nucleotides such as GTP or ATP
to isolated lung cell membranes and despite their being on
ice, p-His was nevertheless generated on NDPK without
the requirement for additional magnesium ions that are
commonly needed by almost all protein kinases (chelating
magnesium did remove the labelling though, possibly by
stripping magnesium bound to membrane phospholipids or
removing the kinase). Yet, this very same NDPK-bound
phosphate rapidly disappeared on transient membrane
warming necessitating careful handling of samples in a
cold room atmosphere. Today, to detect this labile modi-
ﬁcation of p-His, we have a new sensor as illustrated by
Paul Besant and Paul Attwood [5], two experts in the latest
mass spectrometry techniques which can reveal the pres-
ence of this elusive, unstable N-linked amino acid modi-
ﬁcation. Embracing this new technology should widen the
understanding of this p-His generation process. However,
there is a cautionary note to add by invoking another
physics luminary, Werner Heisenberg of uncertainty prin-
ciple fame. Heisenberg said that the energy involved in
measuring something changes that something and therefore
you cannot rely on the answer (albeit, at a quantum level).
Something similar may occur when you ‘look’ but do not
ﬁnd the expected p-His. The very process of ‘biochemical
looking’ can move the unstable phosphate link away from
p-His. This shift occurs because p-His has a high phosphate
energy when attached to the (relatively) unstable link to
histidine 118 in NDPK that when you examine the phos-
pho-status of p-His NDPK in vitro, it is no longer there.
Instead, this unstable phospho-histidine has migrated to
water (hydrolysis) or to any nearby OH group located on
one or more adjacent lower energy sites (on the NDPK
protein, serines S120 or S122 and other neighbours are
examples). We will return to these nearby phospho-serine
sites [4] later but it is sufﬁcient to note that p-serine has a
low energy O–P link and is therefore stable. Thus, the
apparent presence of phospho-serine (p-Ser) in NDPK (or
perhaps other proteins?), often reported, requires rigorous
proof. This may be a fundamental issue in the ﬁeld because
where a protein kinase has never been conﬁrmed in a
biological process and yet p-Ser is always found, then
p-His may have been there all along but may have been
missed making p-Ser the artifact. This is an under appre-
ciated frontier in biochemistry, long ignored by the main-
stream protein kinase explorers, who may (in vain) be
looking for the mysterious underlying p-Ser kinase and
6 Mol Cell Biochem (2009) 329:3–15
123may never ﬁnd it. Of course it also remains possible that
this family of proteins may have some biological functions
under non-native conformations that await discovery.
Advances from the NDPK community of scientists
in 2008–2009
SincethisoriginalNDPKfunctiontobalanceagiventri-and
a di- nucleotide pool has been so well documented for over
50 years, NDPK has often been dismissed as a mere cellular
energy converter churning and re-churning forms of cell
energy such that di-nucleotides (base sugar and two phos-
phates) turn into slightly longer tri-nucleotides and vice
versa.Thispotentialforendlessfutilityismediatedbyaclass
of reactions called reversible near equilibrium ‘ping pong
reactions’ which in fact do have, as we will see, medical
utilityinthat ping (say ATP plus GDP) and pong (phosphate
swapping generating ADP and GTP), followed by the
reverse pong and ping, thus balances cell pools of energy.
However,thissimplicitymasksadarkerside.Ifthisisallthat
NDPK undertakes in a cell, then why do higher organisms
need the eight or perhaps nine different isoforms of NDPK
that exist in mammalian cells for example? What else are
they doing? Some may not even have a phosphorylation
capability. For this family of NDPK proteins, as we come to
realize thatasingleproteincanhavemultiplefunctions,soit
transpires that, despite their apparent small size on reducing
SDS-PAGE gels, this family is also multifunctional. Bio-
chemists often call it a ‘sticky’ protein because it keeps
turning up unexpectedly in ‘unrelated’ processes. Further-
more, individual molecules (monomers) of NDPK are rela-
tively small proteins (about one-third the size of PKA for
example) and yet they can self-assemble spontaneously
comprising at least six members with the additional capa-
bility of acting like self-assembling nano-bots to create
supra-molecularﬁlaments[7].Theyalsomanifestﬂuidityby
being able to switch seamlessly between certain family
members (hetero-hexamers). This self-assembly is underap-
preciated and is one reason why those outside the ﬁeld often
ignore NDPK as being ‘too small’ (typically 18 kDa). Yet,
some isoforms may also act alone when bound to cell mem-
branesandothersarerathershadowyandyetcannotbepinned
down to their exact roles. A minority are involved in the
beating of hair-like cell structures (cilia) because a mutant
NDPK family member has been found in patients who
develop lung disease because their cilia are unable to provide
the motive force needed to expectorate lung mucus [8].
NDPK nomenclature, where next?
The origins of NDPK in the ancient biological world are
elegantly described within this series of articles [9], where
a computer-based (bio-informatic) approach is described to
assess both how (gene duplication) and when (biological
time) NDPK diverged to create the family, perhaps from
one archetypal protein in a lost ancestor. In the case of
NDPK, one early version of the gene self-duplicated on the
immediately adjacent DNA to create a copy that then
mutated differently over time (NDPK-A became NDPK-
B). As we shall see, these two abundant isoforms of NDPK
have different, but overlapping functions, and both are
essential for life outside the womb in rodent models. This
notion is complemented by a multi-author French review
from Marie-Lise Lacombe in Paris with co-workers in
different French institutes [8], who point out how difﬁcult
it is to name this family which, to those who are not NDPK
‘locked in NDPK cell inmates’, can be very confusing due
to their many aliases as either NME (gene name), NDPK-
A, NDPKA, B, C etc., or NM23-H1, H2, H3 etc., or AWD
and yet other names in different model organisms such as
worms. A good example of the confusion arises should you
type NDPK-A or NDPKA or the full name or an alias into a
search engine. Depending on what you type, it is easy to
miss important interacting proteins. To overcome this very
real hindrance to translation and the consequent potential
for patient’s beneﬁt, the bio-informatic resources at the
European Bioinformatic Institute (EBI) in Cambridge (UK)
relevant to this family of proteins are being updated in
collaboration with members of this community and a spe-
ciﬁc ‘interactome’ dataset has been created and maintained
for users. These resources are described in the appendix by
the co-author (SO) and new entrants to the ﬁeld are
encouraged to add to the freely available list, when they
ﬁnd a new interacting protein.
These nomenclature problems have arisen partly
because NDPK keeps on being rediscovered by scientists
working on apparently unrelated ﬁelds in different model
organisms, where the gene may already have been named
(worms and ﬂies are good examples). As we shall see,
discovery and rediscovery of this family in multiple bio-
logical systems are key principles underpinning the hub-
like actions of NDPK with multiple partners that are only
now becoming apparent [8]. This leads to an important idea
that some proteins live solitary lives with few interactions,
others have a few biological friends, whereas a few are
promiscuous hubs that interact with many partners. NDPK
is one of the latter.
The scientist, who stumbles upon NDPK: there is more
than one leitmotif for NDPK
The general scientist should now be sufﬁciently armed to
tackle the more challenging aspects of NDPK biology,
beginning with cancer as a worked example before moving
Mol Cell Biochem (2009) 329:3–15 7
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(HIV), other viruses involved in cancer, newly described
structural roles for this family at the interface of fat and
water and their ability to act as cellular trafﬁc lights in cell
signalling.
Functions in the secondary spread of cancer
Text books of biochemistry state that even normal cells,
when they divide, make DNA replication mistakes as much
as 10% of the time but these are corrected by the cellular
repair machinery. Repair relies on the fact that if base A
has been lost on one DNA strand on the unwound helix,
then using the ﬁdelity of the template T on the other strand,
the missing A can be correctly reinstated. But if both A and
T are lost, say after ionizing radiation damage, then failure
to faithfully correct, DNA introduces ﬁdelity errors in part
driving DNA ‘evolution’ (the net effect may be neutral,
lethal, advantageous). Thus, one might predict that were
NDPK to be involved in this process, then dysfunction of
NDPK might create ‘hypermutator’ organisms and the
evidence for this exists in bacteria and other cells [6].
Hence, with each cell division, a long series of DNA-
protein based accidents combine to destabilise DNA.
Cancers are made of many different kinds of cells and all
cancers shed some cells into the host body. Yet, not all
cancers spread to distant sites via blood or lymph channels.
This spreading process is called metastasis, otherwise
known as the secondary spread of cancer. Some of these
‘shed-cells’ acquire the ability to acquire their own blood
supply and re-grow at different sites (metastases). This
seeding of cancer involves a master set of ‘metastasis-
controlling’ genes (a dozen or so: see www.metastasis-
research.org; accessed Feb 2009).
The role of the ﬁrst NDPK to be discovered (also known
as NDPK-A or NM23-H1; H means human; NM23-M1, M
means mouse etc.) was related to the secondary spread of
the original cancer (NM = non metastatic). After many
decades of ‘cell inmate’ work in cells and animal models of
metastasis, the clinical correlates at a cancer patient level
are only now being translated by Patricia Steeg and col-
leagues in the USA [10, 11], who have now started a trial
of drug-based ‘metastatic control’ [10]. Such a translational
process to a possible therapy spans decades and has even
outlasted some investigators. For example, Jean-Yves
Daniel in France [8] and Edith Postel in the USA [12], who
both retired since the Dundee conference, devoted so much
of their research lives to NDPK-A and NDPK-B, respec-
tively. Both, at the tail end of their careers, created their
mouse models to prove their respective hypotheses in
breast development/cancer metastasis and the regulation of
fetal development. But who will ensure that their knockout
mice are used to advance care at the patient level? These
transitions of senior personnel are pertinent problems in
translational medicine today. Do we need archives of
transitional medical science to make sure multiple life-
times’ of research retain a clear legacy path? Science is not
strong on succession planning. A few ‘taster’ examples of
the multifunctional theme for NDPK follow and the rest are
reviewed by the experts writing in this special issue (and
described brieﬂy at the end).
Drugs and NDPK
Some anti-HIV drugs that are nucleoside analogues are
administered as inactive precursors (pro-drugs) that need a
cell enzyme to make them active by adding phosphate [13].
NDPK may provide that function. Thus, instead of a di-
nucleotide being the recipient of phosphate, a man made,
pro-drug mimicking a nucleotide steals into the NDPK
pocket shielding H118 and NDPK targets the pro-drug as if
it were a bona ﬁde, ping pong di-phosphate bearing reac-
tant. This is only possible because the pro-drug steals into
the middle of the ping pong reaction at a time after the
initial ping (see ‘‘Methods’’ section). This p-His form of
NDPK is transiently highly charged by the attached N–P
phosphate, recently cleaved from a tri-nucleotide, i.e.
during the interval in which phosphate is covalently linked
to a conserved catalytic histidine deep in the pocket of
NDPK (post-ping interval). Because the 40–50 kJ/mol of
phospho-energy is preserved by this N–P linkage within the
cleft, this pre-phosphorylated NDPK pongs its p-His
phosphate to the pro-drug. The phosphorylated pro-drug is
the active species that interferes with HIV replication [13].
Interestingly, in cell models, NDPK-A is up-regulated
during pro-drug exposure, as if the cell can ‘sense’ the
diversion of its ‘correct’ level of NDPK abundance. This
illustrates a recurrent theme that NDPK levels are in some
way self-controlled in cells and are not passive [14]. This
also partly explains why NDPK is discovered and re-dis-
covered because perturbing any cell by adding a new gene
as a rapidly turning over plasmid likely changes cellular
energetic balance. Later, this ﬁnding is speculatively rela-
ted to psoriasis, a skin disease affecting 1% of humans that
is dramatically proliferative in skin progenitors but classi-
cally is non-carcinogenic or metastatic when compared to
other ‘equally’ proliferative skin diseases. To reach that
goal, a small detour is needed.
What constitutes the essential molecular tool kit
for NDPK studies?
Most NDPK specialists exploit this essential histidine N–P
link by mutating it to another amino acid that cannot accept
a phosphate to create a ‘transfer-dead’ protein. The NDPK
community is always willing to make such mutants
8 Mol Cell Biochem (2009) 329:3–15
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should be warned that there is no agreement as to whether
it is best to replace this critical histidine-118 with an
equivalently bulky residue that cannot accept phosphate
such as phenylalanine, asparagine or to mutate to a smaller
residue such as alanine or cysteine. It may be that both
strategies may inﬂuence adjacent regulatory serines in the
protein [14] that are potential targets for other protein
kinases such as CK1 and CK2, suggesting that mutation at
H118 may indirectly affect the ability of NDPK to act as a
protein hub. To AM’s knowledge, the critical experiment
replacing the histidine-118 with a low-energy serine or
threonine capable of accepting phosphate (probably) but
not transferring (probably) needs to be done as an addi-
tional control. Further, given the advances made by the
Zollo group in Naples and their collaborators focusing on
NDPK as a ‘balancing protein–protein hub’ involving
many kinases [14], putting a permanent negative charge in
this site to repel phosphate may also yield interesting
biology with respect to other kinases targeting nearby
serines.
Viruses and NDPK
When cells are invaded by viruses, these intruders hijack
useful cellular protein kinases en route to aid their own
replication. NDPK is no exception. For example, Erle
Robertson informs us that NDPK’s ability to bind viral
proteins is critical when key cellular functions are sub-
verted by the Epstein Barr Virus (EBV) that causes glan-
dular fever and lymphoma [15]. This virus can exist either
stably in the cell (latent phase) or can suddenly replicate
and make new virus after cell stresses. The transition is the
subject of much research outside the NDPK ﬁeld and
NDPK interactions take place with viral proteins released
by EBV during its life cycle [15]. It is as if EBV steals the
cell energy supplier much as an army is critically depen-
dent on its supply lines. Interestingly, protein kinase CK2
(that interacts with NDPK) phosphorylates EB2, one of the
EBV early proteins, thereby facilitating export of EBV
mRNA from the nucleus [16]. Thus, the overlap between
CK2 and NDPK spans important biology in cancer and
other ﬁelds. In a related manner, Massimo Zollo and col-
leagues [14] describe an NDPK protein partner called
Prune that acts as a class-speciﬁc nucleotide cleaver in its
own right, albeit one acting on the NMP class (cyclic AMP
for example). Thus prune protein generates AMP from
cyclic-AMP. In addition, they recently underlined a new
activity of Prune, which is involved on degrading poly-
phosphates and speculate this additional function may be
important for tumour metastasis initiation and angiogene-
sis. They then show how the interaction between Prune and
NDPK-A or NDPK-B changes when prior phosphorylation
of NDPK by protein kinases CK2/CK1 occurs. They go on
to propose a testable model on the balance between prune-
and NDPK-controlled processes positing that this NDPK
‘hub’ manifests plasticity in the context of the activity of
other kinases. In development, Prune was named in fruit
ﬂies because of a prune eye colour mutation (these ﬂies
normally have a red eye) and relates to the original ﬂy
name for NDPK (abnormal wing discs or AWD). Flies
only have one major NDPK isoform, which accounts for
[98% of the total NDPK activity present in the whole
animal (there are other paralogues with unknown func-
tion). There exists an additional ability of certain mutants
of AWD to kill only those (developing) ﬂies with prune
eyes (so called killer-of-prune). The equivalent mamma-
lian Prune generates mononucleotides including AMP
(with the caveat that there are other Prune products from
this emerging science). Treharne et al. [4] also follow an
AMP line of enquiry in cell membranes derived from
biopsies of human airway epithelium. They describe how
AMP differentially controls NDPK’s ability to become
phosphorylated on either histidine (p-His) or serine (p-Ser)
or both. They then show that p-Ser generation is dependent
on the type of base present on the nucleotide supplying the
ping reaction. This was a surprise. As described in the
‘‘Methods’’ section of this overview, the differential pres-
ence of p-Ser depending on whether cell membranes are
exposed to ATP or GTP as phosphate donors should not
happen, if the p-Ser is merely an artifact of ‘energetically-
downhill’ p-His transfer to p-Ser during membrane pro-
cessing given that phosphate merely ‘backs in’ to the
NDPK cleft (i.e. base-blind entry). Hence, this article
inadvertently addresses criticisms towards such ‘non-spe-
ciﬁc’ artifacts in p-Ser generation. A priori, ATP and GTP
should have behaved identically in the reported experi-
ments and yet they did not in a cell membrane environ-
ment exposed to ATP or GTP in vitro. This suggests that
p-Ser generation on NDPK may be a real biological phe-
nomenon as proposed by the Zollo group. Treharne et al.
[4] have a second aim for their paper, namely, to clarify
the literature. By focusing on the effects of AMP on
NDPK, they attempt to clear up the controversy sur-
rounding the potential links between NDPK and the kinase
controlled by AMP, AMPK and the cystic ﬁbrosis protein,
CFTR. They show that AMPK and NDPK can co-precip-
itate. Further, with Karl Kunzelmann in Germany, they
show how this AMPK keeps CFTR shut at baseline until
PKA is activated [17]. Further clariﬁcation (possibly
relating the cancer-related work of Zollo and colleagues on
CK2) between cancer, ion channels and CFTR is also
published [18]. Importantly, CFTR is not the only ion
channel with which NDPK interacts and we will return to
the role of NDPK towards calcium-controlled potassium
ion channels below.
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fatty acids
Following the lead of Mari-Lise Lacombe and colleagues
in Paris [8], it is independently conﬁrmed [19] that NDPK
may bind membrane lipids (but only selected phospholip-
ids, perhaps only with the hexameric form). Thus related
special membrane fats such as the complex cardiolipin that
are found in mitochondrial membranes can bind one iso-
form of NDPK imported into that organelle [8]. Mito-
chondria have a problem in that they are cellular organelles
that need to divide [20] but also fuse with one another as
cell energy demands change (say from stem cell to pro-
liferating cell or after viral insult). During division, mito-
chondria maintain a double layer of fat (the inner and outer
mitochondrial membranes). Yet, they also have to make
ATP and serve it to the cytosol across the very same layers
without disrupting layer integrity on which ATP generation
depends. Like the interior of an onion, cells also have
multiple folded inner membranes in contact with the cell
nucleus [21]. It is of interest that different NDPK isoforms
can act as bridging components in this domain, presumably
clustering selected phospholipids on the ER. It is tempting
to speculate that one monomer of NDPK self-assembles
another NDPK [7] and the (hetero)-hexamer clusters/
approximates phospholipids of certain classes located on
different ER membranes both at the subcellular membrane,
where cell ATP is made in the mitochondria [22] and in
adjacent subcellular membranes in the ER [21]. If NDPK is
structurally important for ER complexity, current ideas
suggest that the very outside tip of each NDPK monomer
has a molecular hook to anchor different types of
phospholipid [21]. Thus, these combined data suggest that
NDPK and its associates not only bridge the network of ER
membranes but also supply new membrane to its outer coat
by shedding vesicles from the ER destined for the Golgi.
These very recent data [23] suggest that the intrinsic ability
of the ER to shed its protein coated membrane into ‘cargo’
vesicles (colourfully called trafﬁc COPS), i.e. proteins
embedded in these nascent fatty spheres destined for export
via the Golgi apparatus is critically dependent on NDPK. In
the corollary, Tien Hsu [24] champions the idea that NDPK
controls the rate-limiting step of the recovery of the plasma
membrane back into the cell interior. In the membrane
recovery process, ﬂask-shaped invaginations are pinched
off from the plasma membrane to maintain steady state
membrane area. So there exists an overlapping theme
whereby the lipid trafﬁc controller NDPK, regulates both
protein arrivals (embedded in ER sourced membrane ves-
icles) and at least one sort of membrane/cargo departure
(endocytosis via the GTP-fuelled membrane cleaver
protein, dynamin) while also maintaining certain kinds
of internal membrane structure. By extension, Hsu and
colleagues [24] suggest that membrane residence time
could be governed for a given cargo membrane protein
receptor (say delivered as a passenger in the membrane) by
altering relative rates of arrival or departure. We will return
to this ‘surface receptor exposure time’ as a unifying theme
at the end.
This combined literature provides an example of nature-
inspired nanotechnology, just as rows of closely spaced
power lines hang between electricity pylons with each
power line being held the correct distance apart from its
neighbour by star-shaped spacers, so one possible struc-
tural function of NDPK becomes apparent [19–24]. This
complex area of research may be summarized as follows:
emerging evidence suggests that the mitochondrial and the
(H2) ER-located isoform manifest an ability to bind certain
lipids. In a related manner, colleagues in the Mayo Clinic
are looking at the efﬁciency of energy transfer from
mitochondria, where they ﬁnd NDPK playing a critical role
[22]. The emerging notion is that, to prevent cell charge
build up as ATP is transported out of a mitochondrion,
NDPK-bearing protein bridges link to relays of other pro-
teins (adenylate kinase is a good example) that act as
conduits from the sites of power generation inside the inner
membrane of mitochondria, to the outer mitochondrial
membrane and beyond to the outer cell membrane.
NDPK as a signal transmitter across plasma membrane
NDPK binds to proteins inside the cell that utilize lipid
anchors to hang from membrane [25]. These internal but
membrane-peripheral proteins are certain types of G pro-
teins (they bind GTP to become active exchanging pre-
bound GDP for GTP often using other proteins as facili-
tators). They act on the integral membrane protein, aden-
ylyl cyclase (AC) embedded in plasma cell membranes,
which binds G proteins and becomes active to synthesise
cAMP (by stitching ATP phosphate to itself). Yet, AC
makes small amounts of cAMP even at rest when no
external stimulus is present. AC has to approximate its two
internal domains to cleave and then cyclise ATP phosphate.
To promote such domain–domain approximation and cre-
ate the AC catalytic site, this cAMP generator needs to
interact with membrane-anchored G proteins to promote
the necessary conformational change. Classically, this
should not happen at baseline, as this protein–protein
interaction requires a signal to make G proteins bind AC. It
is thought that NDPK plays a novel basal generator role by
supplying GTP to the G protein without the external signals
normally needed to promote G protein binding to AC at the
plasma membrane. Tom Wieland [25] in Mannheim
focuses on NDPK-mediated control of this ‘basal function’
of such G proteins. At the Dundee 2007 conference, he
showed how failure of a Zebra Fish plasma membrane to
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membrane, Ed Skolnik from New York has translated a
related basal signalling theme into membrane immunology
in lymphocytes [26]. Serendipitously, his team found
NDPK-B to interact in a yeast-2-hybrid system with an ion
channel that links cell potassium exit to a rise in cell cal-
cium. Furthermore, he has recently advanced the ﬁeld
further by investigating the reversal of this process thus
exemplifying the emerging theme of removal of a p-His by
another protein. This creates congruence with the work of
Tom Wieland and these papers should be compared
because they show that a common mechanism is applied to
a lymphocyte and a beating heart cell to maintain their
respective, essential, baseline functions. Derangement of
the balance of this p-His generation versus the reverse,
dephospho-his function may be relevant to many processes
and Massimo Zollo and colleagues [14] also set out a
similar ‘balance versus destabilisation’ view in relation to
the NDPK regulator prune. Thus, NDPK hubs are a nascent
theme in NDPK biology today [4].
How can we study the human relevance of NDPK?
To delineate NDPK function, a number of tractable model
systems have been developed, where NDPK is only present
either as a single gene or only has a few isoforms. Thus in
this series, Paul Fisher, who recently was awarded the
accolade of Australian Scientist of the year for 2008, shows
how roles of NDPK could be speciﬁed in the developmental
cycle of the social amoeba Dictyostelium (Dicty) from
which source, NDPK was originally crystallized. This
ancient organism has the ability to aggregate thousands of
dispersed single cells into a moving slug in response to
cyclic nucleotides [27]. Fisher points out that Dicty has the
further advantage of acting as a developmentally regulated,
lineage proven model system ideally suited for investiga-
tion of mammalian development. In an analogous manner,
the role of NDPK in marine sponges [28] and frog embryos
[9] exempliﬁes roles in (respectively), nuclear localization
and the composition of ﬁnal cell types in the developing
retina. Thus, Shin-Ichi Ohnuma (London) reveals [9] that
the retina is an excellent model for the study of NDPK
because the small number of retinal cell types, their inter-
actions and their lineages are well understood. The links
between the spread and the composition of cell types in the
ﬁnal developed retina and the fact that in mammals, the
prune protein also shows retinal localization remain to be
investigated. Importantly, the developing retina is very
oxygen sensitive and the failure of newborn life after the
oxygen surge at birth is examined in the work of Edith
Postel and colleagues [12], who unambiguously demon-
strate that when doubly deleted for two widely expressed
sub-types (NDPK A and B), this double deletion causes
uniform perinatal death of the double null offspring. These
animals may also die because they are anaemic as they are
unable to transform their fetal liver-made nucleated red cell
precursors into mature circulating enucleated erythrocytes
and therefore die at birth. This ﬁnding shares features
described by Shin-Ichi Ohnuma and colleagues [9], who
link NDPK to controllers of cell cyclins and to the devel-
opmental work of Tien Hsu in fruit ﬂies [24]. This double
knockout ﬁnding is contrasted by the work of Jean-Yves
Daniel and colleagues, who knocked out NDPK-A alone in
mouse and created a viable mouse [8]. But, surviving
pregnant adult females are unable to breast feed their litters
despite making milk normally [8]. Note once again the
relationship here to breast development and hormonal
changes in lactating breast as the functions of NDPK are
being unraveled which could relate to metastasis. It remains
to be shown whether knockout of NDPK-B alone is detri-
mental but at the very least, dramatic effects on heart failure
are predicted from the work in Zebra ﬁsh. Finally, we return
to the theme of DNA. DNA has a direction, i.e. is a vector
and not a scalar quantity by virtue of asymmetry of the
phosphates that link the deoxyriboses to one another
through the phosphate chain. David Kaetzel [6] addresses
our gap in understanding between DNA modiﬁcation and
the tail end of helix breaks (three prime end) looking at the
action of NDPK as an exonuclease (see also early work
from Postel’s group). Progression to metastasis has a strong
mutational component and NDPK-A possesses an exonu-
clease activity that is required for metastasis suppression.
Thus, David Kaetzel [6] points out that a part of NM23’s
metastasis suppressor function may be to resist mutations
that lead to metastasis. We await links between this enig-
matic DNA function that of the modiﬁcation of DNA during
lactation and the work of Maja Herak Bosnar and col-
leagues in Zagreb [28], who study the differential propen-
sity of NDPK mutants to move between cell compartments
in a tractable system in marine sponges.
Thus, many tools are now at hand to unravel NDPK that
complement the molecular tool kit based on mutant NDPK
constructs (see above). However, the philosopher Karl
Popper argued vehemently against those who try to move
from the speciﬁc to the general, claiming that this process
of induction was ﬂawed (he cites the old idea from the
discovery of Australia that until then, all swans are white,
until a black one turns up). Yet, the ancient presence of
different NDPK group members often as single genes in
simple organisms has the distinct advantage that NDPK
function can be dissected. Thus, in answer to Popper, cell
lineages are understood during development and predic-
tions can be made. Thus, we look forward to work in
progress in worms, ﬁsh, yeast, slugs and sponges. One
example follows that might unify themes, with due defer-
ence to the eminent Popper.
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John Dewey, the famous American pragmatist philosopher
devoted much of his life to the consequences of ideas
pointing out that it was not enough to have an idea as a
‘cell inmate’—society funds us to do useful work. Today,
this is re-named as translational medicine. It becomes
axiomatic that if we can understand how the NDPK family
can do so much to so many processes despite being so few,
then we can perhaps advance the rate of translational
medicine. This is happening, albeit in only one case to
date—metastasis control.
Metastasis prematurely terminates the lives of many,
who present to a doctor with their ﬁrst symptoms or signs
(spread or colour change in a skin mole, a breast lump,
poor urinary stream, or gradual reduction in frequency of
passing stool). As discussed by Patricia Steeg (USA) at the
meeting in Dundee, too often at presentation, the original
cancer has already seeded its deadly metastable assassins to
distant biological shores. Thus, after this particular horse
has bolted, how do we translate the understanding of
NDPK in metastasis? Patricia Steeg and colleagues are
testing a drug to enhance NDPK function [11]. Will this
work? Perhaps, a recent paper in Cancer Gene Therapy
[29] aptly illustrates the Dewey translational theme: This
article has the following statement in the abstract [AM
comments are interjected in square brackets]:
‘The intravenous injection of IONP-PLL [a nano parti-
cle; a self replicating machine capable of making ﬂuores-
cent NDPK in high concentration inside cells] carrying
NM23-H1-GFP plasmid DNA [nm23 is an alternative
nomenclature for one widely expressed isoform of NDPK
that is involved in breast development and metastasis]
signiﬁcantly extended the survival time of an experimental
pulmonary metastasis mouse model. In the IONP-PLL/
NM23-H1-GFP-treated group, metastasis was clearly sup-
pressed compared with the group treated with free NM23-
H1-GFP plasmid [the self-replicating machine without
a nano-key fob to get it into cells]. Furthermore, this
gene therapy combined with cyclophosphamide treatment
[a commonly used anti-cancer drug] resulted in longer
survival times and greater suppression of metastasis
growth. In conclusion, treatment with IONP-PLL nano-
particles incorporating the NM23-H1gene is an efﬁcient
gene therapy method, and it is even more effective in
combination with chemotherapy’.
In a nutshell, these authors have veriﬁed, albeit in mice,
Patricia Steeg’s seminal discovery from three decades ago
that a cancer cell that readily metastasizes changes its
propensity to colonise distant sites dependent on the
expression of NDPK. We await human trials on the NDPK-
enhancing drug in metastatic breast cancer with interest.
Given that this group has extended their observations to
mouse ovarian cancer, a cancer that is often both silent and
metastatic at presentation, the urgency is ampliﬁed. One
only has to turn to the internet and type in ‘Jade Goody’ or
‘Alma Cogan’ to see how disseminated cancer (cervix and
ovary, respectively) wrecks talented lives prematurely. The
physician in AM hopes that Li et al. [29] apply their
technology to humans suffering from metastatic cancer
with immediate effect.
Can we arrive at a consensus on why NDPK keeps
turning up in diverse biology?
Tien Hsu (who won the prize for his work during the
Dundee Conference) elegantly demonstrated how metas-
tasis, signalling and membrane-turnover might be different
manifestations of a common theme [24]. He uses epithelial
tubular development in fruit ﬂies as his model system and
suggests that the developing trachea might be optimized in
its layered structure using NDPK as a signal molecule by
controlling both tracheal morphogenesis and its vascular
supply from captured blood vessels. The inner epithelial
surface of the trachea is lined by an apical membrane
capping the tips of each of the columnar epithelial cells [4].
This apical cell membrane is typically held constant at
*6% of the total surface area of each columnar cell (in
humans typically 25 l
2 bearing several hundred cilia) and
makes tight contact through protein–protein structures with
lateral adjacent apical membranes of neighbouring cells.
This apical barrier has a different lipid composition and
gates the external world that will eventually be in contact
with tracheal air in post natal life. The trachea is ﬁlled with
a ﬂuid elaborated by the apical cell membrane itself before
birth. How is this surface area regulated? A lumen is made
in embryonic life by pumping ions into the lumen and
water follows. To keep the size of the lumen under control,
water and salt pumping across the apical membrane must
be regulated together with membrane area. This brings in
regulation of ion channels again (Skolnik and colleagues,
Treharne and colleagues). Hsu and colleagues elegantly
show how NDPK acts as a regulator of the balance between
supply and loss of apical vesicular structures as they
migrate from and return to sub apical zones (source of new
membrane originally made in ER—see above; surplus area
is retrieved by endocytosis). This balance idea has reso-
nance with that of others described above [17–21] on the
synthesis of such membrane components in the ER, where
NDPK is important for COP II vesicle release and ER
structure. A possible common factor linking cell growth/
apical turnover and cell migration/metastasis is the func-
tion of cargo proteins that are surface resident in the
interval between membrane-cargo arrival and departure
(CFTR is a good apical example, ﬁbroblast growth recep-
tors in developing cells are another). Thus, the residence
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as passengers on vesicles could be a unifying theme
because their residence time could reﬂect their ability to
interact with cognate extracellular ligands. Residence time
could be ﬁne tuned by altering the balance between
receptor arrival rates and retrieval rates. Tien Hsu suggests
[24] that endocytic control could govern availability of
surface growth receptors driving cell migration towards the
cognate receptors located within standing external gradi-
ents for these receptors. His idea could explain how NDPK
dysfunction might cause tracheal dysgenesis and in other
modes, cause so many larval growth defects (NDPK as
AWD). Interestingly, AWD is proposed as a regulator of
the energetic terminal step of endocytosis mediated by
dynamin (also called shibire in ﬂies), whose intrinsic
GTPase function is very low without NDPK. In this
respect, NDPK supplies the necessary GTP molarity near
dynamin to pinch off the neck of the ﬂask-shaped nascent
vesicle, thus kicking the vesicle into the cytoplasm. The
excitement of this model is that it is testable in Dicty
because this simple organism has good tools to test its
motility towards standing gradients of small molecules
such a cAMP.
NDPK function, where next?
As we look forward to the next meeting, NDPK continues
to surprise. NDPK/NM23 seems to be important for the
entry of stem cells to a proliferative fate through external
membrane interaction with the outside proteins using stem
cell membrane proteins such as MUC1 and their cleavage
products [30]. In a related manner, NDPK is abnormally
elevated in the proliferative plaques of psoriatric skin [31].
Interestingly, severe psoriasis is also reported as a com-
plication of changing of antiretroviral therapy [32]. This is
unexplained and brings us back to a clinical ﬁnding that
despite massive cell turnover, psoriatic skin does not turn
to cancer—is this a latent manifestation of the NM in
NM23? Could the propensity of psoriasis to be precipitated
when HIV therapy is changed relate to NDPK dysfunction?
Thus, this relationship of NDPK to drug therapy for HIV
needs further study. The accessibility of psoriatic skin in
animal models should make for rapid progress and might
create a model whereby knocking down the excess NDPK
could ameliorate proliferation rates and reduce plaque size
but might simultaneously increase metastatic risk. Perhaps
this is a good test for the NDPK community as it is almost
axiomatic that proliferation signals are controlled through
NDPK [33].
This brings us back to mechanism through the structure
of DNA and master gene activation as recurrent themes in
the ﬁeld [2]. We were graced at the Dundee meeting by an
address from Sir David Lane, of p53 fame, on prospects for
the future of cancer therapy. In the accompanying papers to
this series, Joon Kim from Korea reminds us that p53 and
NDPK are linked to one another [34] perhaps through the
DNA binding domain of p53 and a protein kinase called
STRAP (noting that CK1 and CK2, which target NDPK are
also important in p53 control). Cancer is not the only place
where NDPK and disease interact. In Dundee, we also
received a master class on the function of the pancreatic
islet from Anjan Kowluru (Detroit), who told us about his
investigations into the Goto-Kakizaki rat, an animal model
of defective insulin release characterized by phospho-his-
tidine deﬁciency [35]. Could membrane residence time be
involved here, given that vesicle fusion is critical in insulin
release? He ﬁnds that NDPK fails to become loaded with
p-His in pancreatic islets from this rat model [35]. He is
hunting the protein involved and has updated us in this
series with new data on the links between fats as signal
molecules and NDPK function [35]. Thus, once again fat
and NDPK are linked here in a metabolic rather than a
structural context. Determining the reasons will no doubt
lead us to a new in vivo NDPK function. No doubt sci-
entists will come across NDPK repeatedly and on cue, new
actors are being discovered as this goes to press. One focus
of the overview has been cell energy, another has been
cellular viral invasion and both have now been linked
through glyceraldehyde-3-phosphate dehydrogenase, a key
regulator of cell energy supply in glycolysis and a proposed
regulator of viral invasion [36]. Interestingly, cancer cells
rely on glycolysis to survive and importantly, NDPK can
bind to this dehydrogenase [37] and may control its ability
to interact with DNA by forming a heterodimeric complex.
Thus, we come full circle from DNA through cell energy to
cell function.
Conclusions
If life in a cell takes place on a crowded three-dimensional
stage, then it is likely that NDPK controls the rates of exit
and entry of critical actors. This is NDPK as a choreog-
rapher. NDPK may drive critical actors because it is both
an energy supplier and a developmental program director
in fetal life preparing embryos for neonatal life. NDPK
must of necessity interact with some or all of these actors
guiding them to regulate their time and density on stage
thus altering their ability to interact with (and hence
inﬂuence) the external audience. This is NDPK in action.
In summary, the sustained drive of fellow scientists to
develop the notions overviewed here and thereby to
understand one single protein family has been their labor of
love. We urge you to read their individual voyages of
discovery. Reference [37] is a good place to start that
journey; bonne chance.
Mol Cell Biochem (2009) 329:3–15 13
123Acknowledgments Apologies to those whose original papers could
not be quoted for space reasons. The principal sponsor for the Dundee
Conference was CRUK with generous support from the Association
for International Cancer Research, EuroCareCF European Coordina-
tion Action for Research in Cystic Fibrosis, Cystic Fibrosis Founda-
tion (USA), IS.M. (Dundee) Ltd, Dundee City Council, Ablett &
Stebbing, BioDundee, Famous Grouse, Merck Chemicals Ltd. AM
wishes to thank the University of Dundee and the Tayside Convention
Bureau for their help with the conference. The conference proceed-
ings may be found at www.dundee.ac.uk/mchs/ndpk (accessed on
March 9). AM’s laboratory is supported by grants from the Wellcome
Trust (WT079965; WT086370) and the Cystic Fibrosis Trust (PJ538).
AM wishes to thank his research team for their efforts in making the
conference a success.
Appendix: Accessing NDPK data from public domain
databases
Protein sequence and functional information
Protein sequence and functional information is accessible
from the protein sequence database, UniProtKB (www.
uniprot.org). The nomenclature recommended by the
NDPK community is being incorporated into the appro-
priate entries and all possible synonyms are also listed to
enable a comprehensive search. A simple text search,
advanced search and BLAST capabilities are available on
the UniProtKB website. Users can access speciﬁc infor-
mation from a number of delineated ﬁelds, such as protein
function, subcellular location, enzyme-speciﬁc information
(catalytic activity, cofactors, metabolic pathway, regulatory
mechanisms) and physical features such as domain com-
position and post-translational modiﬁcations. Records may
also be downloaded for local installation and use in a
number of alternative formats. Gene Ontology mappings
for all selected records can be accessed from the appro-
priate UniProtKB entries.
Specialists in this ﬁeld are encouraged to contribute to
the annotation of speciﬁc proteins by using the form pro-
vided in the documentations section.
Molecular interaction data
The IntAct molecular interaction database (www.ebi.ac.uk/
intact) provides a freely available, open source database
system and analysis tools for protein interaction data. All
interactions are derived from literature curation or direct
user submissions. A ﬁle of all interaction data related to
proteins, which are members of the NDPK family namely
proteins found in InterPro family IPR001564 (Nucleoside
diphosphate kinase, core) has been assembled and will be
maintained for use by scientists interested in this area of
work. Interactions are available in a speciﬁc ﬁle from
the FTP site in PSI-XML2.5 format [38] and can be
downloaded from there and directly visualised using tools
such as Cytoscape (www.cytoscape.org). Alternatively,
users can search for the interactions made by individual
proteins via the IntAct website, using gene names (or
synonyms), protein names (or synonyms), or accession
numbers such as a UniProtKB identiﬁer. Interaction net-
works can be expanded by built-in visualisation and query
tools and the ﬁnal output also downloaded in the PSI-
XML2.5 or PSI-MITAB 2.5 tab-delineated formats. All
data is fully MIMIx-compliant [39]. Users either generat-
ing de novo interaction data or requiring additional publi-
cations to be added to the dataset should contact the
database via the website. Dataset download: ftp://ftp.ebi.
ac.uk/pub/databases/intact/current/psi25/datasets/NDPK/
Epilogue
The comment on Ortega and other luminaries on the gap
between science in the laboratory and the funding provided
by people at large arose from New Scientist Magazine
(December 8th 2008), which generated much disagreement
in subsequent correspondence in the early part of 2009.
Undoubtedly, there exists a disconnection between the
millions, who followed the very public death of Jade
Goody from disseminated cervical cancer and the difﬁ-
culties in funding metastasis research by the scientiﬁc
community. This needs urgent attention. Perhaps the next
meeting of the NDPK community should overlap with a
meeting of the CK2 kinase community, after all, both
kinases when disrupted, cause different manifestations of
cancer and no doubt, other diseases which will come to
light as the roles of NDPK become appreciated by main-
stream biochemistry. We hope that, as the tools become
easier to use, a bioinformatic approach will help widen
such understanding for all.
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